Skip to main content
. Author manuscript; available in PMC: 2012 Feb 6.
Published in final edited form as: Clin Gastroenterol Hepatol. 2008 Oct 9;6(12):1361–1369. doi: 10.1016/j.cgh.2008.07.032

Table 3.

IBD – Parameters at Diagnosis

AA Non-AA OR CI
N=138 % N=1268 %
Age at Diagnosis
<6y 10 7 206 16 0.40 0.21–0.78
6–12Y 56 41 587 46 0.79 0.55–1.13
>12y 72 52 475 37 1.82 1.28–2.59
AA Non-AA OR CI
N=138 % N=1268 %
Age at Symptom Onset
<6y 14 10 240 19 0.48 0.27–0.86
6–12y 60 43 644 51 0.75 0.52–1.06
>12y 64 46 384 30 1.99 1.40–2.84
AA Non-AA OR CI
N=79 % N=640 %
Hgb <10mg/dL 31 39 109 17 3.15 1.92–5.17
AA Non-AA OR CI
N=69 % N=555 %
ESR >20 mm/hr 55 80 304 55 3.24 1.76–5.97
AA Non-AA OR CI
N=55 % N=474 %
Alb <3mg/dL 15 27 93 20 1.54 0.81–2.90
AA Non-AA OR CI
N=138 % N=1268 %
EIMC present 17 12 113 9 1.44 0.83–2.47
AA Non-AA OR CI
N=138 % N=1268 %
Received Any Immunomodulators 78 57 515 41 1.90 1.33–2.71
AA Non-AA OR CI
N=78 % N=515 %
Received Steroids 58 74 401 78 0.82 0.48–1.43
Alone
AA Non-AA OR CI
N=94 % N=741 %
Height - abnormal z-score 21 22 194 26 0.81 0.49–1.35
AA Non-AA OR CI
N=99 % N=787 %
Weight - abnormal z-score 35 35 241 31 1.24 0.80–1.92